|
WO2011143111A1
|
|
Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity
|
|
US2011124720A1
|
|
Compositions and methods for treating immune disorders
|
|
WO2011022056A2
|
|
PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF
|
|
WO2010151338A2
|
|
Myostatin inhibitor enhancement of musculoskeletal repair
|
|
WO2010151638A1
|
|
Jnk inhibitors for use in treating spinal muscular atrophy
|
|
US2011135672A1
|
|
Hla-g compositions and methods of use thereof
|
|
WO2011022103A2
|
|
Ganglioside epitopes for treating guillain-barre syndrome
|
|
US2010297160A1
|
|
High Molecular Weight Amyloid Beta As a Carrier for the Oral Delivery of Vaccine Antigens
|
|
US2010278907A1
|
|
Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
|
|
CA2759079A1
|
|
Breast cancer susceptibility gene gt198 and uses thereof
|
|
WO2010081104A1
|
|
Use of polymeri zable quaternary ammonium compounds to inhibit endogenous mmps in tooth dentin
|
|
US2011047631A1
|
|
Heat shock protein deficiencies as model systems for brain pathology and cancer
|
|
WO2010078198A1
|
|
Shortened alk1 regulatory fragment
|
|
WO2010042754A2
|
|
Methods and systems for mineralization of demineralized tissue
|
|
WO2010042685A2
|
|
Inhibitors of the atb(0,+) transporter and uses thereof
|
|
US2009312778A1
|
|
Apparatus for removing plaque from an arterial wall and method of use therefor
|
|
WO2009137475A2
|
|
Compositions and methods for diagnosing late-onset alzheimer's disease
|
|
WO2009100116A1
|
|
Oligodendrocyte precursor cell composition and methods of use
|
|
WO2009092017A1
|
|
Biomarkers for hpv-induced cancer
|
|
US2009190816A1
|
|
Systems and methods for rescaling image intensities with diffusion MRI to synthesize complex diffusive geometries
|
